創傷治療用生物製剤の中東・アフリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Middle East & Africa Wound Care Biologics Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810547)・商品コード:DBMR810547
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年8月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:中東・アフリカ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、創傷治療用生物製剤の中東・アフリカ市場について調査・分析し、創傷治療用生物製剤の中東・アフリカ市場動向、市場予測、セグメント別分析、創傷治療用生物製剤市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Middle East & Africa wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Middle East & Africa wound care biologics market are listed below:

• MiMedx
• WRIGHT MEDICAL GROUP N.V
• Smith and Nephew
• INTEGRA LIFE SCIENCES CORPORATION
• Mölnlycke Health Care AB
• ConvaTec Inc

The Middle East & Africa wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type segment the Middle East & Africa wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment is expected to dominate the Middle East & Africa wound care biologics market with highest market shares. However, allografts segment is expected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the Middle East & Africa wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Middle East & Africa wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user Middle East & Africa wound care biologics market is segmented into hospitals, wound care centres and ambulatory centres, clinics, community healthcare centers. In 2018, hospitals are expected to dominate the Middle East & Africa wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into following countries:
• South Africa

• Rest of Middle East & Africa
The report covers the present scenario and the growth prospects of the Middle East & Africa wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 30
1.1 Objectives Of The Study 30
1.2 Market Definition 30
1.3 Overview Of Middle East-And Africa Wound Care Biologics Market 30
1.4 Currency And Pricing 31
1.5 Limitation 31
1.6 Markets Covered 32
2 Market Segmentation 34
2.1 Markets Covered 34
2.2 Geographic Scope 35
2.3 Years Considered For The Study 36
2.4 Currency And Pricing 36
2.5 Research Methodology 37
2.6 Primary Interviews With Key Opinion Leaders 40
2.1 Dbmr Market Position Grid 41
2.2 Dbmr Market Challenge Matrix 42
2.3 Secondary Sources 43
2.4 Assumptions 43
3 Market Overview 44
3.1 Drivers 46
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46
3.1.2 Increasing Incidences Of Burn Cases 46
3.1.3 Rising Number Of Geriatric Population 47
3.1.4 Innovation In Wound Care Biologics 48
3.1.5 New Product Launches 50
3.2 Restrains 50
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50
3.2.2 Risk Of Skin Substitue Failure 51
3.3 Opportunities 52
3.3.1 3D Skin Printing 52
3.3.2 Awareness Programs 53
3.4 Challenges 54
3.4.1 Lack Of Wound Management Services 54
4 Executive Summary 55
5 Premium Insights 58
6 Middle East-And Africa Wound Care Biologics Market, By Product Type 63
6.1 Overview 64
6.2 Synthetic Skin Grafts 66
6.3 Growth Factors 67
6.3.1 Platelet Derived Growth Factor (Pdgf) 70
6.3.2 Platelet Rich Plasma (Prp) 70
6.3.3 Epidermal Growth Factors (Egf) 70
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71
6.3.6 Talactoferrin Alfa 71
6.3.7 Thrombin Peptide 72
6.3.8 Keratinocy Growth Factor (Kgf) 72
6.4 Allografts 73
6.5 Xenografts 74
7 Middle East-And Africa Wound Care Biologics Market, By Wound Type 76
7.1 Overview 77
7.2 Wounds 78
7.2.1 Surgical Wound 80
7.2.1.1 Skin Surgery 81
7.2.1.1.1 Wound Closure 82
7.2.1.1.2 Skin Biopsy 82
7.2.1.1.3 Skin Flap 82
7.2.1.1.4 Skin Graft 82
7.2.1.1.5 Others 82
7.2.1.2 Cosmetic Procedure 83
7.2.1.2.1 Brest Enhancement 84
7.2.1.2.2 Facial Contouring 85
7.2.1.2.3 Facial Rejuvenation: 85
7.2.1.2.4 Body Contouring 85
7.2.1.2.5 Skin Rejuvenation 85
7.2.1.2.6 Others 86
7.2.1.3 Gynecologic Procedures 86
7.2.1.3.1 Pubovaginalis Sling 86
7.2.1.3.2 Pelvic Floor Reconstruction 87
7.2.1.3.3 Rectocele Repair Surgery 87
7.2.1.3.4 Others 87
7.2.1.4 Gastrointestinal Procedure 87
7.2.1.4.1 General Gastrointestinal Surgery 88
7.2.1.4.2 Hernia 89
7.2.1.4.3 Others 89
7.2.2 Acute Wounds 90
7.2.3 Chronic Wounds 90
7.2.4 Traumatic Wounds 91
7.3 Burns 91
7.3.1 Ulcers 92
7.3.2 Diabetic Ulcers 94
7.3.3 Pressure Ulcer 94
7.3.4 Venous Ulcer 95
7.3.5 Others 95
8 Middle East-And Africa Wound Care Biologics Market, By End User 96
8.1 Overview 97
8.2 Hospitals 99
8.3 Wound Care Centers 100
8.4 Ambulatory Surgical Centers 101
8.5 Clinics 103
8.6 Community Healthcare Center 104
9 Middle East-And Africa Wound Care Biologics Market: Geography 105
9.1 Middle East & Africa 105
9.1.1 South Africa 116
9.1.2 Rest Of Middle East & Africa 123
10 Middle East-And Africa Wound Care Biologics Market, Company Landscape 124
10.1 Company Share Analysis: Middle East-And Africa 124
11 Company Profile 125
11.1 Mimedx. 125
11.1.1 Company Overview 125
11.1.2 Revenue Analysis: 125
11.1.3 Company Share Analysis: 126
11.1.4 Product Portfolio 126
11.1.5 Recent Developments 127

11.2 Organogenesis Inc 128
11.2.1 Company Overview 128
11.2.2 Geographic Presence 128
11.2.3 Company Share Analysis: 129
11.2.4 Product Portfolio 129
11.2.5 Recent Developments 130
11.3 Integra Lifesciences 131
11.3.1 Company Overview 131
11.3.2 Revenue Analysis 131
11.3.3 Company Share Analysis: 132
11.3.4 Product Portfolio 132
11.3.5 Recent Developments 133
11.4 Convatec Inc. 134
11.4.1 Company Overview 134
11.4.2 Revenue Analysis 134
11.4.3 Company Share Analysis: 135
11.4.4 Product Portfolio : 135
11.4.5 Recent Developments 135
11.5 Acell Inc. 136
11.5.1 Company Overview 136
11.5.2 Product Portfolio 136
11.5.3 Recent Developments 137
11.6 Allosource 138
11.6.1 Company Overview 138
11.6.2 Product Portfolio 138
11.6.3 Recent Developments 139
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 140
11.7.1 Company Overview 140
11.7.2 Product Portfolio 140
11.7.3 Recent Developments 140
11.8 Amnio Technology, Llc 141
11.8.1 Company Overview 141
11.8.2 Product Portfolio 141
11.8.3 Recent Developments 142
11.9 Amniox Medical, Inc. 143
11.9.1 Company Overview 143
11.9.2 Product Portfolio 143
11.9.3 Recent Developments 144
11.10 Anika Therapeutics, Inc. 145
11.10.1 Company Overview 145
11.10.2 Revenue Analysis 145
11.10.3 Product Portfolio 146
11.10.4 Recent Developments 146
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 147
11.11.1 Company Overview 147
11.11.2 Geographicpresence 147
11.11.3 Product Portfolio 148
11.11.4 Recent Developments 148
11.12 Kerecis 149
11.12.1 Company Overview 149
11.12.2 Geographical Presence 149
11.12.3 Product Portfolio 150
11.12.4 Recent Developments 150
11.13 Marine Polymer Technologies, Inc 151
11.13.1 Company Overview 151
11.13.2 Product Portfolio 151
11.13.3 Recent Developments 151
11.14 Mölnlycke Health Care Ab 152
11.14.1 Company Overview 152
11.14.2 Revenue Analysis 152
11.14.3 Product Portfolio 153
11.14.4 Recent Developments 153
11.15 Osiris Therapeutics, Inc. 154
11.15.1 Company Overview 154
11.15.2 Revenue Analysis 154
11.15.3 Product Portfolio 155
11.15.4 Recent Developments 155
11.16 Skye Biologics Inc. 156
11.16.1 Company Overview 156
11.16.2 Product Portfolio : 156
11.16.3 Recent Development: 157
11.17 Smith And Nephew 158
11.17.1 Company Overview 158
11.17.2 Revenue Analysis 158
11.17.3 Product Portfolio 159
11.17.4 Recent Developments 159
11.18 Solsys Medical. 160
11.18.1 Company Overview 160
11.18.2 Product Portfolio 161
11.18.3 Recent Developments 161
11.19 Vericel Corporation. 162
11.19.1 Company Overview 162
11.19.2 1.1.2 Revenue Analysis 162
11.19.3 Product Portfolio 163
11.19.4 Recent Developments 163
11.20 Wright Medical Group N.V 164
11.20.1 Company Overview 164
11.20.2 1.1.2 Revenue Analysis 164
11.20.3 Product Portfolio 165
11.20.4 Recent Developments 166
12 Related Reports 167

List Of Tables
Table 1 Middle East-And Africa Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 51
Table 2 Middle East-And Africa Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 52
Table 3 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 54
Table 4 Middle East-And Africa Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 55
Table 5 Middle East-And Africa Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 59
Table 6 Middle East-And Africa Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 61
Table 7 Middle East-And Africa Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million) 64
Table 8 Middle East-And Africa Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 65
Table 9 Middle East-And Africa Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million) 65
Table 10 Middle East-And Africa Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 66
Table 11 Middle East-And Africa Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 67
Table 12 Number Of Cosmetic Surgery, 2016 & 2017 69
Table 13 Middle East-And Africa Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 70
Table 14 Middle East-And Africa Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 72
Table 15 Middle East-And Africa Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 74
Table 16 Middle East-And Africa Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 78
Table 17 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 79
Table 18 Middle East-And Africa Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 79
Table 19 Middle East-And Africa Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million) 84
Table 20 Middle East-And Africa Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 85
Table 21 Middle East-And Africa Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 86
Table 22 Statistics For Ambulatory Surgical Center. U.S. 87
Table 23 Middle East-And Africa Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 88
Table 24 Middle East-And Africa Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 89
Table 25 Middle East-And Africa Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 90
Table 26 Middle East & Africa Wound Care Biologics Market, By Country, Usd Million (2016-2025) 95
Table 27 Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 95
Table 28 Middle East & Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 96
Table 29 Middle East & Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 96
Table 30 Middle East & Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97
Table 31 Middle East & Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 97
Table 32 Middle East & Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 98
Table 33 Middle East & Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99
Table 34 Middle East & Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 99
Table 35 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100
Table 36 Middle East & Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 100
Table 37 Middle East & Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million) 101
Table 38 South Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 102
Table 39 South Africa Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 103
Table 40 South Africa Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103
Table 41 South Africa Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 42 South Africa Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 43 South Africa Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 44 South Africa Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106
Table 45 South Africa Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 106
Table 46 South Africa Gastrointestinal Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107
Table 47 South Africa Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 107
Table 48 South Africa Wound Care Biologics, By End User, 2016-2025, (Usd Million) 108
Table 49 Rest Of Middle East & Africa Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 109




【レポートのキーワード】

創傷治療用生物製剤

★調査レポート[創傷治療用生物製剤の中東・アフリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810547)販売に関する免責事項を必ずご確認ください。
★調査レポート[創傷治療用生物製剤の中東・アフリカ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆